De novo donor-specific human leukocyte antigen antibodies early after kidney transplantation

Transplantation

Volumn 98, Issue 12, 2014, Pages 1310-1315

  Heilman, Raymond L ^a   Nijim, Ala ^a   Desmarteau, Yvonne M ^a   Khamash, Hasan ^a   Pando, Marcelo Jorge ^a   Smith, Maxwell L ^a   Chakkera, Harini A ^a   Huskey, Janna ^a   Valdez, Riccardo ^a   Reddy, Kunam Sudhakar ^a  

^a MAYO CLINIC   (United States)

Author keywords

Antibody mediated rejection; De novo donor specific antibodies; Kidney transplant; Protocol biopsy

Indexed keywords

CREATININE; LEUKOCYTE ANTIBODY; LEUKOCYTE ANTIGEN; ANTIBODY; HLA ANTIGEN; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2;

ACUTE GRAFT REJECTION; ADULT; ANTIBODY MEDIATED REJECTION; ANTIBODY SPECIFICITY; ANTIGEN SPECIFICITY; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DONOR SELECTION; FEMALE; GLOMERULITIS; GLOMERULUS FILTRATION RATE; GRAFT SURVIVAL; HIGH RISK POPULATION; HLA MATCHING; HUMAN; HUMAN TISSUE; IMMUNOASSAY; IMMUNOPATHOGENESIS; KIDNEY BIOPSY; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; KIDNEY TUBULE DISORDER; MALE; NEPHRITIS; PRIORITY JOURNAL; RISK ASSESSMENT; SURVIVAL PREDICTION; SURVIVAL RATE; TUBULITIS; AGED; BIOPSY; GRAFT REJECTION; HISTOCOMPATIBILITY TEST; IMMUNOLOGY; KIDNEY FAILURE, CHRONIC; MIDDLE AGED; RETROSPECTIVE STUDY; TIME;

ADULT; AGED; ANTIBODIES; BIOPSY; COHORT STUDIES; FEMALE; GRAFT REJECTION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 84925936798     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0000000000000216     Document Type: Article

References (19)

1. Wiebe C, Gibson IW, Blydt-Hansen TD, et al. Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant. Am J Transplant 2012; 12: 1157.
2. Gaston RS, Cecka JM, Kasiske BL, et al. Evidence for antibody-mediated injury as a major determinant of late kidney allograft failure. Transplantation 2010; 90: 68.
3. Ginevri F, Nocera A, Comoli P, et al. Posttransplant de novo donorspecific HLA antibodies identify pediatric kidney recipients at risk for late antibody-mediated rejection. Am J Transplant 2012; 12: 3355.
4. Everly MJ, Everly JJ, Arend LJ, et al. Reducing de novo donor-specific antibody levels during acute rejection diminishes renal allograft loss. Am J Transplant 2009; 9: 1063.
5. Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150: 604.
6. Einecke G, Sis B, Reeve J, et al. Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure. Am J Transplant 2009; 9: 2520.
7. Hidalgo LG, Campbell PM, Sis B, et al. De novo donor-specific antibody at the time of kidney transplant biopsy associates with microvascular pathology and late graft failure. Am J Transplant 2009; 9: 2532.
8. Loupy A, Suberbielle-Boissel C, Hill GS, et al. Outcome of subclinical antibody-mediated rejection in kidney transplant recipients with preformed donor-specific antibodies. Am J Transplant 2009; 9: 2561.
9. Gloor JM, Sethi S, Stegall MD, et al. Transplant glomerulopathy: subclinical incidence and association with alloantibody. Am J Transplant 2007; 7: 2124.
10. Sis B, Campbell PM, Mueller T, et al. Transplant glomerulopathy, late antibody-mediated rejection and the ABCD tetrad in kidney allograft biopsies for cause. Am J Transplant 2007; 7: 1743.
11. Einecke G, Mengel M, Hidalgo L, et al. The early course of kidney allograft rejection: defining the time when rejection begins. Am J Transplant 2009; 9: 483.
12. Wavamunno MD, O'Connell PJ, Vitalone M, et al. Transplant glomerulopathy: ultrastructural abnormalities occur early in longitudinal analysis of protocol biopsies. Am J Transplant 2007; 7: 2757.
13. Sis B, Jhangri GS, Riopel J, et al. A new diagnostic algorithm for antibody-mediated microcirculation inflammation in kidney transplants. Am J Transplant 2012; 12: 1168.
14. Loupy A, Lefaucheur C, Vernerey D, et al. Complement-binding anti-HLA antibodies and kidney-allograft survival. N Engl J Med 2013; 369: 1215.
15. Halloran PF, de Freitas DG, Einecke G, et al. An integrated view of molecular changes, histopathology and outcomes in kidney transplants. Am J Transplant 2010; 10: 2223.
16. Sis B, Jhangri GS, Bunnag S, et al. Endothelial gene expression in kidney transplants with alloantibody indicates antibody-mediated damage despite lack of C4d staining. Am J Transplant 2009; 9: 2312.
17. Lefaucheur C, Loupy A, Hill GS, et al. Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation. J Am Soc Nephrol 1398; 21: 1398.
18. Sis B, Mengel M, Haas M, et al. Banff '09 meeting report: antibody mediated graft deterioration and implementation of Banff working groups. Am J Transplant 2010; 10: 464.
19. Solez K, Colvin RB, Racusen LC, et al. Banff 07 classification of renal allograft pathology: updates and future directions. Am J Transplant 2008; 8: 753.